Please check your internet connection and try again.
# Linagliptin
## Overview
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin hormone concentrations, lowering fasting and postprandial glucose levels in a glucose-dependent manner. Unlike other DPP-4 inhibitors, it is primarily excreted via the hepatobiliary system.
## Primary Indications
Type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycemic control.
## Adult Dosing
5 mg orally once daily. May be taken with or without food.
## Pediatric Dosing
Safety and effectiveness in pediatric patients (under 18 years) have not been established.
## Dose Adjustments
* **Renal Impairment:** No dosage adjustment indicated; safe for use in patients with severe renal impairment or end-stage renal disease.
* **Hepatic Impairment:** No dosage adjustment required.
## Contraindications
* History of hypersensitivity reaction to linagliptin (e.g., anaphylaxis, angioedema, exfoliative skin conditions).
## Adverse Effects
* **Common:** Nasopharyngitis, hypoglycemia (when used with secretagogues or insulin), hyperuricemia.
* **Serious:** Pancreatitis (post-marketing reports), bullous pemphigoid, severe arthralgia, hypersensitivity reactions.
## Key Drug Interactions
* **Strong P-glycoprotein/CYP3A4 inducers (e.g., rifampin):** May decrease linagliptin efficacy. If combined, monitor glycemic control closely; increasing the dose of linagliptin is not recommended due to fixed dosing.
## Monitoring
* **HbA1c:** Assess response typically every 3–6 months.
* **Pancreatitis:** Monitor for persistent, severe abdominal pain.
* **Bullous Pemphigoid:** Monitor for blistering or erosions.
## Clinical Pearls
* Linagliptin is unique among DPP-4 inhibitors because it does not require renal dose adjustments, making it a preferred choice in patients with chronic kidney disease.
* It does not generally cause weight gain.
* If a dose is missed, take it as soon as remembered, but do not take two doses on the same day.
* As with all incretin mimetics, assess for signs/symptoms of pancreatitis and discontinue if suspected.
***
**Educational Disclaimer:** This information is for educational purposes only and does not constitute medical advice. Always verify current prescribing information in the manufacturer's package insert or via institutional clinical protocols before prescribing or administering medication.
